The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Thu., May. 9, 4:38 AM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #64. Thermo Fisher Scientific Life Technologies Corporation

Acquirer: Thermo Fisher Scientific (TMO)
Acquiree: Life Technologies Corporation (LIFE)
Details: Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ:LIFE), a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012).

Thermo Fisher Scientific is engaged in serving science. Co.'s segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products; and Laboratory Products and Biopharma Services, which provides virtually things needed for the laboratory.

Thermo Fisher Scientific SEC Filing Email Alerts Service


Open the TMO Page at The Online Investor »

Thermo Fisher Scientific is engaged in serving science. Co.'s segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products; and Laboratory Products and Biopharma Services, which provides virtually things needed for the laboratory.

Thermo Fisher Scientific SEC Filing Email Alerts Service


Open the LIFE Page at The Online Investor »

Company Name:  Thermo Fisher Scientific Inc
Stock buyback:  TMO buyback
Website:  www.thermofisher.com
Sector:  Biotechnology
Number of ETFs Holding TMO:  104
Total Market Value Held by ETFs:  $25.48B
Total Market Capitalization:  $218.93B
% of Market Cap. Held by ETFs:  11.64%
Company Name:  aTyr Pharma Inc
Website:  www.atyrpharma.com
Sector:  Biotechnology
Number of ETFs Holding LIFE:  3
Total Market Value Held by ETFs:  $4.52M
Total Market Capitalization:  $115.00M
% of Market Cap. Held by ETFs:  3.93%
 

May 9, 2024    4:38 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Biotechnology M&A - Slide 64 of 83 | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.